Newbridge Financial Services Group, Inc. Dia Medica Therapeutics Inc. Transaction History

Newbridge Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$2.29 - $3.88 $551 - $935	-241 Reduced 15.96%	1,269 $3,000
Q3 2021 Oct 27, 2021	BUY	$3.1 - $4.32 $3,090 - $4,307	997 Added 194.35%	1,510 $6,000
Q1 2021 Sep 07, 2021	BUY	$7.76 - $10.43 $667 - $896	86 Added 20.14%	513 $5,000
Q3 2020 Sep 07, 2021	BUY	$3.91 - $7.15 $1,669 - $3,053	427 New	427 $2,000

4.22M

8.2K

200

Ticker DMAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,443,100
Market Cap $128M
Description
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.